Skip to main content
OpenTrials

Clinical trial condition

Orthomyxoviridae Infections

Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.

1,811 public trials 85 recruiting studies
Refine in advanced search Browse all conditions

Orthomyxoviridae Infections trial results

Completed

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People

NCT00992784

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Güglingen, Baden-Wurttemberg, Germany
  • GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Rudersberg, Baden-Wurttemberg, Germany
  • GSK Investigational Site Weinheim, Baden-Wurttemberg, Germany
View all 24 locations
View Trial Details
Completed

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years

NCT00771615

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Anaheim, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Stockbridge, Georgia, United States
View Trial Details
Completed

A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults

NCT00920374

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Dresden, Saxony, Germany
  • GSK Investigational Site Dresden, Saxony, Germany
  • GSK Investigational Site Dresden, Saxony, Germany
  • GSK Investigational Site Dresden, Saxony, Germany
View Trial Details
Completed

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults

NCT01196975

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Wichita, Kansas, United States
  • GSK Investigational Site Elkridge, Maryland, United States
  • GSK Investigational Site Endwell, New York, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children

NCT01198756

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Harrisburg, Arkansas, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
View all 33 locations
View Trial Details
Completed

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age

NCT02242643

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Dothan, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
View all 66 locations
View Trial Details

Related conditions